George L. Sing - Feb 25, 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**George L. Sing
Stock symbol
REGN
Transactions as of
Feb 25, 2022
Transactions value $
-$2,473,000
Form type
4
Date filed
3/1/2022, 03:03 PM
Previous filing
Jan 5, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$1.24M -2K -6.66% $621.00 28K Feb 25, 2022 Direct
transaction REGN Common Stock Sale -$614K -1K -3.57% $614.00 27K Feb 28, 2022 Direct
transaction REGN Common Stock Sale -$617K -1K -3.7% $617.00 26K Feb 28, 2022 Direct
holding REGN Common Stock 750 Feb 25, 2022 by Spouse
holding REGN Common Stock 400 Feb 25, 2022 by Spouse/Cust Son
holding REGN Common Stock 1K Feb 25, 2022 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.